Prediction of mucositis risk secondary to cancer therapy: a systematic review of current evidence and call to action
On behalf of The Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO)
Dive into the research topics of 'Prediction of mucositis risk secondary to cancer therapy: a systematic review of current evidence and call to action'. Together they form a unique fingerprint.